ArticleHealth science reports2026
Global, Regional, and National Epidemiology of Postpartum Hemorrhage (1990-2021): A Statistical Analysis of Incidence, Mortality, and DALYs.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global, Regional, and National Epidemiology of Postpartum Hemorrhage (1990-2021): A Statistical Analysis of Incidence, Mortality, and DALYs.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Postpartum hemorrhage (PPH) is a leading global cause of maternal mortality and morbidity. This study utilizes global burden of disease (GBD) data to assess its long-term trends in incidence, mortality, and disability-adjusted life years (DALYs). Methods: Using data from the GBD, we analyzed age-standardized incidence, mortality, and DALY rates among reproductive-aged women (15-49 years). Trend analysis was conducted via Joinpoint regression to estimate annual percentage changes (APCs), while future burden projections were modeled using Bayesian age-period-cohort (BAPC) analysis. Results: From 1990 to 2021, the global age-standardized incidence rate (ASIR) of PPH declined significantly from 998.26 (95% UI: 654.55-1,438.33) to 722.16 (95% UI: 482.99-1,022.71) per 100,000 population. The estimated annual percentage change (EAPC) was -0.83% (95% UI: -0.90% to -0.77%). Projections suggest this downward trend will continue, with ASIR expected to reach 321.17 (95% UI: 302.55-359.30) by 2035. In 2021, women aged 20-24 years continued to exhibit the highest DALYs, amounting to 749,063 years (95% UI, 629,108.37-894,035.97). From 1990 to 2021, the proportion of DALYs among women of reproductive age attributable to iron deficiency-related PPH increased from 17.19% (95% UI, 8.65% to 21.48%) to 17.96% (95% UI, 8.67% to 23.95%). Conclusion: A sustained decline in the incidence of PPH over the past thirty years-a trend projected to continue through 2035, reflecting the ongoing effectiveness of public health interventions. We also found a potential association with iron deficiency, alongside a consistently higher disease burden observed among women aged 20-24 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.